110 related articles for article (PubMed ID: 8442017)
21. Relative potencies of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls derived from hepatic porphyrin accumulation in mice.
van Birgelen AP; DeVito MJ; Akins JM; Ross DG; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1996 May; 138(1):98-109. PubMed ID: 8658519
[TBL] [Abstract][Full Text] [Related]
22. Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
Schrenk D; Buchmann A; Dietz K; Lipp HP; Brunner H; Sirma H; Münzel P; Hagenmaier H; Gebhardt R; Bock KW
Carcinogenesis; 1994 Mar; 15(3):509-15. PubMed ID: 8118936
[TBL] [Abstract][Full Text] [Related]
23. Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part II. Biochemical effects.
Viluksela M; Stahl BU; Birnbaum LS; Rozman KK
Toxicol Appl Pharmacol; 1997 Oct; 146(2):217-26. PubMed ID: 9344889
[TBL] [Abstract][Full Text] [Related]
24. Relative differences in aryl hydrocarbon receptor-mediated response for 18 polybrominated and mixed halogenated dibenzo-p-dioxins and -furans in cell lines from four different species.
Olsman H; Engwall M; Kammann U; Klempt M; Otte J; Bavel Bv; Hollert H
Environ Toxicol Chem; 2007 Nov; 26(11):2448-54. PubMed ID: 17941736
[TBL] [Abstract][Full Text] [Related]
25. The role of time as a quantifiable variable of toxicity and the experimental conditions when Haber's c x t product can be observed: implications for therapeutics.
Rozman KK; Doull J
J Pharmacol Exp Ther; 2001 Mar; 296(3):663-8. PubMed ID: 11181890
[TBL] [Abstract][Full Text] [Related]
26. Comparative toxicity of PCBs and related compounds in various species of animals.
McConnell EE
Environ Health Perspect; 1985 May; 60():29-33. PubMed ID: 2992923
[TBL] [Abstract][Full Text] [Related]
27. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
28. Risk assessments of polychlorinated dibenzo- p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in food.
Larsen JC
Mol Nutr Food Res; 2006 Oct; 50(10):885-96. PubMed ID: 17009211
[TBL] [Abstract][Full Text] [Related]
29. The tissue distribution of 2,3,7,8-chlorine substituted dibenzo-p-dioxins in humans who died of cancer.
Muto H; Shinada M; Abe T; Takizawa Y
Life Sci; 1991; 48(17):1645-57. PubMed ID: 2016995
[TBL] [Abstract][Full Text] [Related]
30. Calculation of 2,3,7,8-TCDD equivalent concentrations of complex environmental contaminant mixtures.
Eadon G; Kaminsky L; Silkworth J; Aldous K; Hilker D; O'Keefe P; Smith R; Gierthy J; Hawley J; Kim N
Environ Health Perspect; 1986 Dec; 70():221-7. PubMed ID: 3830107
[TBL] [Abstract][Full Text] [Related]
31. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose.
van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
Arch Toxicol; 2014 Mar; 88(3):637-46. PubMed ID: 24363026
[TBL] [Abstract][Full Text] [Related]
32. Toxic equivalency factors of polychlorinated dibenzo-p-dioxins in an ovulation model: validation of the toxic equivalency concept for one aspect of endocrine disruption.
Gao X; Son DS; Terranova PF; Rozman KK
Toxicol Appl Pharmacol; 1999 Jun; 157(2):107-16. PubMed ID: 10366543
[TBL] [Abstract][Full Text] [Related]
33. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
[TBL] [Abstract][Full Text] [Related]
34. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
35. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
36. Toxicity equivalents and EPA's risk assessment of 2,3,7,8-TCDD.
Barnes DG
Sci Total Environ; 1991 May; 104(1-2):73-86. PubMed ID: 1871591
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.
Toyoshiba H; Walker NJ; Bailer AJ; Portier CJ
Toxicol Appl Pharmacol; 2004 Jan; 194(2):156-68. PubMed ID: 14736496
[TBL] [Abstract][Full Text] [Related]
38. Thyroid follicular lesions induced by oral treatment for 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds in female Harlan Sprague-Dawley rats.
Yoshizawa K; Walker NJ; Nyska A; Kissling GE; Jokinen MP; Brix AE; Sells DM; Wyde ME
Toxicol Pathol; 2010 Dec; 38(7):1037-50. PubMed ID: 20924081
[TBL] [Abstract][Full Text] [Related]
39. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
40. Relationship between the biological potency of polychlorinated dibenzo-p-dioxins and their electronic states.
Kobayashi S; Saito A; Ishii Y; Tanaka A; Tobinaga S
Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2100-5. PubMed ID: 1797431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
